Latest / The Vox Markets Podcast
2043: Q&A with hVIVO CEO, Mo Khan
Watch on YouTube
We sat down with Mo Khan, CEO of hVIVO #HVO, to discuss their latest £2 million contract and what it means for the future of hMPV research. With a successful pilot study already completed, hVIVO is now gearing up for the final stage of its hMPV characterisation study, paving the way for future human challenge trials.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.